Related Experiment Video
Updated: Apr 28, 2026

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
A case of logopenic primary progressive aphasia with C9ORF72 expansion and cortical florbetapir binding
Laure Saint-Aubert1, Catherine Sagot2, David Wallon3
1Inserm, imagerie cérébrale et handicaps neurologiques, UMR 825; F-31059, Toulouse, France Université de Toulouse, UPS, imagerie cérébrale et handicaps neurologiques, UMR 825; CHU Purpan, Place du Dr Baylac, F-31059, Toulouse, Cedex 9, France.
Abstract:
We report the case of a 65-year-old woman, clinically diagnosed with the logopenic variant of primary progressive aphasia (PPA), and carrier of C9ORF72 expansion, despite cerebrospinal fluid biomarkers suggesting Alzheimer's disease (AD). She underwent structural MRI, metabolic PET, and amyloid PET imaging using florbetapir. Comparison with healthy controls revealed widespread hypometabolism, left sided cortical atrophy, and an increased cortical amyloid load. No difference in amyloid binding was found between the patient and predemential AD patients. This case provides evidence of amyloidopathy in a carrier of C9ORF72 expansion exhibiting a clinical profile of the logopenic variant of PPA.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Huntington Disease l: Introduction

